Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | LGND | KNSA | ||
| Company | Akero Therapeutics Inc | Ligand Pharm | Kiniksa Pharmaceuticals International Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.52 | 226.47 | 54.97 | ||
| High | 54.83 | 233.98 | 57.72 | ||
| Low | 54.37 | 226.20 | 54.45 | ||
| Latest | 54.65 | 228.36 | 57.62 | ||
| Change | +0.10 | +0.92 | +2.35 | ||
| % Change | +0.18% | +0.40% | +4.25% | ||
| Volume | 15,312,200 | 221,100 | 763,700 | ||
| 20-Day Average Volume | 2,420,955 | 223,050 | 905,065 | ||
| Previous Close | 54.55 | 227.44 | 55.27 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.38 | 223.95 | 47.58 | ||
| 20-Day Raw Stochastic | 78.26% | 61.05% | 99.38% | ||
| 20-Day Relative Strength | 65.57 | 56.93 | 71.80 | ||
| Weighted Alpha | +16.80 | +105.77 | +102.24 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.39% since 12/01/25 | -5.55% since 04/27/26 | +32.13% since 04/27/26 | ||
| Low | 54.29 on 12/05/25 | 220.06 on 04/30/26 | 45.01 on 04/28/26 | ||
| High | 54.83 on 12/08/25 | 244.14 on 04/28/26 | 57.72 on 05/04/26 | ||
| 1-Month | |||||
| %Chg | +1.13% since 11/07/25 | +14.41% since 04/02/26 | +18.03% since 04/02/26 | ||
| Low | 54.02 on 11/10/25 | 198.55 on 04/10/26 | 41.49 on 04/21/26 | ||
| High | 54.83 on 12/08/25 | 247.38 on 04/27/26 | 57.72 on 05/04/26 | ||
| 3-Month | |||||
| %Chg | +22.62% since 09/08/25 | +15.14% since 02/04/26 | +32.40% since 02/04/26 | ||
| Low | 41.77 on 09/15/25 | 178.72 on 02/26/26 | 41.12 on 02/24/26 | ||
| High | 54.83 on 12/08/25 | 247.38 on 04/27/26 | 57.72 on 05/04/26 | ||
| 6-Month | |||||
| %Chg | +0.68% since 06/06/25 | +20.54% since 11/04/25 | +49.51% since 11/04/25 | ||
| Low | 41.77 on 09/15/25 | 175.89 on 01/13/26 | 37.02 on 01/15/26 | ||
| High | 57.35 on 06/27/25 | 247.38 on 04/27/26 | 57.72 on 05/04/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,499,006 | 4,575,878 | 4,409,947 | ||
| Shares Outstanding, K | 82,324 | 20,038 | 76,535 | ||
| Annual Sales | 0 | 268,090,000 | 677,560,000 | ||
| Annual Net Income | -252,060,000 | 124,450,000 | 59,010,000 | ||
| Last Quarter Sales | 0 | 59,670,000 | 214,270,000 | ||
| Last Quarter Net Income | -81,570,000 | 44,780,000 | 22,590,000 | ||
| 60-Month Beta | -0.40 | 1.20 | 0.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 11/07/25 | 2.02 on 02/26/26 | 0.27 on 04/28/26 | ||
| Earnings Date | 02/27/26 | 05/07/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | 2.500 on 04/03/07 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 39.01 | 61.41 | ||